Atherosclerosis imaging using PET: Insights and applications.
Accepted version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Abstract
PET imaging is able to harness biological processes to characterise high-risk features of atherosclerotic plaque prone to rupture. Current radiotracers are able to track inflammation, microcalcification, hypoxia, and neoangiogenesis within vulnerable plaque. 18 F-fluorodeoxyglucose (18 F-FDG) is the most commonly used radiotracer in vascular studies and is employed as a surrogate marker of plaque inflammation. Increasingly, 18 F-FDG and other PET tracers are also being used to provide imaging endpoints in cardiovascular interventional trials. The evolution of novel PET radiotracers, imaging protocols, and hybrid scanners are likely to enable more efficient and accurate characterisation of high-risk plaque. This review explores the role of PET imaging in atherosclerosis with a focus on PET tracers utilised in clinical research and the applications of PET imaging to cardiovascular drug development.
Description
Keywords
Journal Title
Conference Name
Journal ISSN
1476-5381
Volume Title
Publisher
Publisher DOI
Rights
Sponsorship
Academy of Medical Sciences (unknown)
British Heart Foundation (None)
Evelyn Trust (unknown)
Wellcome Trust (104492/Z/14/Z)
Engineering and Physical Sciences Research Council (EP/N014588/1)
Medical Research Council (MR/N028015/1)
Wellcome Trust (211100/Z/18/Z)
Cambridge University Hospitals NHS Foundation Trust (CUH) (146281)
Cambridge University Hospitals NHS Foundation Trust (CUH) (unknown)